Home
GSK in focus

GSK in focus

GSK in focus gives you news and views about healthcare and what we do to help people live healthier, happier lives.

Some of these features have appeared in the pictorial banner at the top of our home page or on some of the section landing pages. Generally, more recent and updated stories can be found higher up this page.

GlaxoSmithKline: a global leader in dermatology
GSK recently acquired Stiefel Laboratories, the world’s largest independent dermatology company.

London Marathon: more than a race
Some call it the suburban man’s Everest. For others it’s a lifetime ambition. For those taking part, it’s a life-changing race that tests runners to the limits.

Epilepsy: 'a disease once sacred'
Once referred to as 'the sacred disease', but what is epilepsy, what causes it and how is it treated?

Cystic fibrosis: the vicious cycle
The reality for patients with this life-threatening disease can be hard. What is GSK doing to help them?

Parkinson's - the 'shaking palsy'
To mark World Parkinson's Disease Day on 11 April, we look at this common neuro-degenerative disease – its causes, prevalence and treatments.

Cervical cancer: a personal perspective

The outlook for preventing one of the world’s top female cancer killers is better than it has ever been.

'Tablets with holes' - simplicity with sophistication

Creating tablets with holes is at the heart of a new generation of controlled-release tablets.

Ten years of GSK's lymphatic filariasis programme

Ten years and 750 million tablets later, progress is being made in the fight against lymphatic filariasis.

Horlicks: helping Britain to sleep better and feel better
With a rich heritage of over 130 years, Horlicks is a popular hot milky drink in Asia and the UK.

COPD: beyond a 'smoker's cough'

COPD is preventable but not curable. What is this relatively unknown disease - and how is it treated?

Osteoporosis: the silent disease
Osteoporosis is a disease in which bones become brittle. There's no cure, but treatment can strengthen bones and help reduce the risk of fractures.

PHASE: now wash your hands!
Every year three million people globally die of diarrhoeal disease, most of them children. It is one of the world’s biggest killers, yet one of the most easily preventable.

Alzheimer’s: the long goodbye
Alzheimer’s disease was first diagnosed just over 100 years ago, yet it remains an area of high unmet medical need with a heavy burden of care.

Inhalers for asthma: making them count
Using miniature engineering, GSK has become the first pharmaceutical company to use counters in its metered dose inhalers.

Hay fever: a seasonal inconvenience
Hay fever may be a massive inconvenience to its sufferers, but the good news is that there are medicines available to take away the discomfort.

A new era in cervical cancer prevention
New vaccines will ultimately help to prevent the infections that cause most cervical cancer in wome, saving thousands of lives around the world in the future.

Climate change: working for a brighter future
With much of the world discussing climate change, it’s clear that humanity needs to clean up its act and reduce the production of pollution.

Diabetes: looking to the future
Diabetes can be controlled by a balance of diet, exercise and medication, but what exactly is the disease and where is research taking companies such as GSK?

Happy birthday, Glaxo
From milk to medicines, Glaxo has been a recognised name for 100 years.

Obesity: weighty matters
The world is getting weightier and the trends suggest that it will continue. Why is obesity such a problem - and what can be done about it?

Challenging cancer
Cancer is the leading cause of death worldwide. That’s why GlaxoSmithKline is searching for new cancer treatments that attack the disease on several fronts.

After the tsunami
Two years after the Indian Ocean tsunami disaster, GlaxoSmithKline is helping to rebuild communities and support healthcare schemes.

Vaccines: investing for life
Vaccines help to protect people from disease, yet the search continues for vaccines that will halt the spread of cancer and diseases such as malaria and AIDS.

The gift of life
GlaxoSmithKline is a major donor of medical products to disaster relief efforts. But how does it get donated medicines to areas devastated by disaster?

The science of sport
Top athletes know that they need to avoid dehydration to compete effectively. GlaxoSmithKline’s Lucozade Sport Science Academy is on hand to help.

Kicking the habit
Over a billion people worldwide smoke tobacco, yet it is the leading preventable cause of death globally. So what is the fascination with this lethal leaf?

Every breath you take
Asthma is a growing problem in developed countries with 100-150 million people affected by this breathing disorder.

A GSK scientist in the Marathon des Sables
Pushing personal limits to help cancer patients.

From mice to men
Pharmaceutical companies carry out a series of clinical trials in humans to test each investigational drug for the potential to become a new medicine.

The menace of malaria
Feared since the days of the Roman Empire, malaria remains a major health problem.

The white plague
Tuberculosis (TB) was once thought to be a disease of the past, but it has returned in a big way.

The legacy of great science
The work of Nobel Laureate Gertrude Elion lives on.

Eliminating lymphatic filariasis
Through partnership and donation of albendazole, GSK is working to help eliminate this terrible disease.

Purple haze: making Ribena
Ribena is one the most popular brands in the UK. But how is it produced?